Coronary Stent By Product (bare Metal Stents, Drug Eluting Stents, Bioresorbable Vascular Scaffold) - Global Industry Analysis And Forecast To 2023
Published On : June 2022 Pages : 180 Category: Medical Devices Report Code : HC061039
Industry Outlook and Trend Analysis
The Coronary Stent Market was worth USD 6.27 billion in 2017 and is expected to reach approximately USD 12.08 billion by 2023, while registering itself at a compound annual growth rate (CAGR) of 7.56% during the forecast period. Increasing aged populace is considered as a high effect rendering driver for this market. The most recent treatments accessible in cardiac care are anticipated to expand the life expectancy of the elderly populace subset. Thereby, with expanding aged populace the interest for coronary stents is foreseen to ascend over the figure period. Advancements in technology in coronary stents are additionally foreseen to bolster the market development. These progressions are enhancing precision, giving extra abilities to upgrade the work process, and encouraging the reduction of errors.
Product Outlook and Trend Analysis
The DES segment comprising biodegradable and non-biodegradable DES is the leading the product segment of the market and is anticipated to continue leading over the upcoming years. The BVS products are foreseen to develop significantly over the estimate time frame. Launch of new products of Magmaris and Magnitude are foreseen to expand the interest for BVS products.
Regional Outlook and Trend Analysis
Geographically, North America was driving the market in 2017 and is foreseen to exhibit a similar pattern over the forecast period. North America is the business pioneer inferable from the reimbursement schemes, increasing rates of diseases, and existence of substantial number of organizations which help in product availability. Increasing aged populace, unhealthy way of life and expanding medicinal tourism in Asia Pacific is anticipated to drive the market.
Competitive Insights
The leading players in the market are Boston Scientific, Cook Group, Biotronik, B. Braun Melsungen, Abbott Laboratories, C. R. Bard, Stentys, MicroPort Scientific, Medtronic and Terumo Corporation. The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
The Coronary Stent Market is segmented as follows-
By Product
- Drug Eluting Stents
- Bioresorbable Vascular Scaffold
- Bare Metal Stents
By Region
- North America
- U.S
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest of Asia Pacific
- Rest of the World
- Brazil
- South Africa
- Saudi Arabia
- United Arab Emirates
- Others
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2017 to 2023?
- What will be the industry market growth from 2017 to 2023?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Coronary Stent Market, By Product, Estimates and Forecast, 2014-2023($Million)
· Bare Metal Stents
· Drug Eluting Stents
· Bioresorbable Vascular Scaffolds
· Coronary Stent Market, By Region, Estimates and Forecast, 2014-2023($Million)
o North America
§ North America Coronary Stent Market, By Country
o U.S. Coronary Stent Market
o Canada Coronary Stent Market
o Mexico Coronary Stent Market
o Europe
§ Europe Coronary Stent Market, By Country
o Germany Coronary Stent Market
o UK Coronary Stent Market
o France Coronary Stent Market
o Russia Coronary Stent Market
o Italy Coronary Stent Market
o Rest of Europe Coronary Stent Market
o Asia-Pacific
§ Asia-Pacific Coronary Stent Market, By Country
o China Coronary Stent Market
o Japan Coronary Stent Market
o South Korea Coronary Stent Market
o India Coronary Stent Market
o Southeast Asia Coronary Stent Market
o Rest of Asia-Pacific Coronary Stent Market
o South America
§ South America Coronary Stent Market
o Brazil Coronary Stent Market
o Argentina Coronary Stent Market
o Columbia Coronary Stent Market
o South Africa Coronary Stent Market
o Rest of South America Coronary Stent Market
o Middle East and Africa
§ Middle East and Africa Coronary Stent Market
o Saudi Arabia Coronary Stent Market
o UAE Coronary Stent Market
o Egypt Coronary Stent Market
o Nigeria Coronary Stent Market
o South Africa Coronary Stent Market
o Rest of MEA Coronary Stent Market
Table of Contents
1. Introduction
1.1. Report Description
1.2. Research Methodology
1.2.1. Secondary Research
1.2.2. Primary Research
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.2.3.1. Emerging Countries to Offer Lucrative Growth Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market States and Outlook (2017-2023)
4.1.2. Canada Market States and Outlook (2017-2023)
4.1.3. Mexico Market States and Outlook (2017-2023)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market States and Outlook (2017-2023)
4.2.2. France Market States and Outlook (2017-2023)
4.2.3. UK Market States and Outlook (2017-2023)
4.2.4. Russia Market States and Outlook (2017-2023)
4.2.5. Italy Market States and Outlook (2017-2023)
4.2.6. Rest of Europe Market States and Outlook (2017-2023)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market States and Outlook (2017-2023)
4.3.2. Japan Market States and Outlook (2017-2023)
4.3.3. Korea Market States and Outlook (2017-2023)
4.3.4. India Market States and Outlook (2017-2023)
4.3.5. Rest of Asia-Pacific Market States and Outlook (2017-2023)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market States and Outlook (2017-2023)
4.4.2. Argentina Market States and Outlook (2017-2023)
4.4.3. Columbia Market States and Outlook (2017-2023)
4.4.4. Rest of South America Market States and Outlook (2017-2023)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market States and Outlook (2017-2023)
4.5.2. UAE Market States and Outlook (2017-2023)
4.5.3. Egypt Market States and Outlook (2017-2023)
4.5.4. Nigeria Market States and Outlook (2017-2023)
4.5.5. South Africa Market States and Outlook (2017-2023)
4.5.6. Rest of MEA Market States and Outlook (2017-2023)
5. Coronary Stent Market, By Product
5.1. Introduction
5.2. Global Coronary Stent Sales, Revenue and Market Share by Product (2017-2027)
5.2.1. Global Coronary Stent Sales and Sales Share by Product (2017-2027)
5.2.2. Global Coronary Stent Revenue and Revenue Share by Product (2017-2027)
5.3. Bare Metal Stents
5.3.1. Global Bare Metal Stents Sales and Growth Rate (2017-2027)
5.4. Drug Eluting Stents
5.4.1. Global Drug Eluting Stents Sales and Growth Rate (2017-2027)
5.5. Bioresorbable Vascular Scaffolds
5.5.1. Global Bioresorbable Vascular Scaffolds Sales and Growth Rate (2017-2027)
6. Coronary Stent Market, By Region
6.1. Introduction
6.2. Global Coronary Stent Sales, Revenue and Market Share by Regions
6.2.1. Global Coronary Stent Sales by Regions (2017-2027)
6.2.2. Global Coronary Stent Revenue by Regions (2017-2027)
6.3. North America Coronary Stent by Countries
6.3.1. North America Coronary Stent Sales and Growth Rate (2017-2027)
6.3.2. North America Coronary Stent Revenue and Growth Rate (2017-2027)
6.3.3. North America Coronary Stent Sales by Countries (2017-2027)
6.3.4. North America Coronary Stent Revenue (Million USD) by Countries (2017-2027)
6.3.5. U.S.
6.3.5.1. United States Coronary Stent Sales and Growth Rate (2017-2027)
6.3.5.2. United States Coronary Stent Revenue (Millions USD) and Growth Rate (2017-2027)
6.3.6. Canada
6.3.6.1. Canada Coronary Stent Sales and Growth Rate (2017-2027)
6.3.6.2. Canada Coronary Stent Sales (Millions USD) and Growth Rate (2017-2027)
6.3.7. Mexico
6.3.7.1. Mexico Coronary Stent Sales and Growth Rate (2017-2027)
6.3.7.2. Mexico Coronary Stent Revenue (Millions USD) and Growth Rate (2017-2027)
6.4. Europe Coronary Stent by Countries
6.4.1. Europe Coronary Stent Sales and Growth Rate (2017-2027)
6.4.2. Europe Coronary Stent Revenue and Growth Rate (2017-2027)
6.4.3. Europe Coronary Stent Sales by Countries (2017-2027)
6.4.4. Europe Coronary Stent Revenue (Million USD) by Countries (2017-2027)
6.4.5. Germany
6.4.5.1. Germany Coronary Stent Sales and Growth Rate (2017-2027)
6.4.5.2. Germany Coronary Stent Revenue (Millions USD) and Growth Rate (2017-2027)
6.4.6. UK
6.4.6.1. UK Coronary Stent Sales and Growth Rate (2017-2027)
6.4.6.2. UK Coronary Stent Revenue (Millions USD) and Growth Rate (2017-2027)
6.4.7. France
6.4.7.1. France Coronary Stent Sales and Growth Rate (2017-2027)
6.4.7.2. France Coronary Stent Revenue (Millions USD) and Growth Rate (2017-2027)
6.4.8. Russia
6.4.8.1. Russia Coronary Stent Sales and Growth Rate (2017-2027)
6.4.8.2. Russia Coronary Stent Revenue (Millions USD) and Growth Rate (2017-2027)
6.4.9. Italy
6.4.9.1. Italy Coronary Stent Sales and Growth Rate (2017-2027)
6.4.9.2. Italy Coronary Stent Revenue (Millions USD) and Growth Rate (2017-2027)
6.4.10. Rest of Europe
6.4.10.1. Rest of Europe Coronary Stent Sales and Growth Rate (2017-2027)
6.4.10.2. Rest of Europe Coronary Stent Revenue (Millions USD) and Growth Rate (2017-2027)
6.5. Asia-Pacific
6.5.1. Asia-Pacific Coronary Stent Sales and Growth Rate (2017-2027)
6.5.2. Asia-Pacific Coronary Stent Revenue and Growth Rate (2017-2027)
6.5.3. Asia-Pacific Coronary Stent Sales by Countries (2017-2027)
6.5.4. Asia-Pacific Coronary Stent Revenue (Million USD) by Countries (2017-2027)
6.5.5. China
6.5.5.1. China Coronary Stent Sales and Growth Rate (2017-2027)
6.5.5.2. China Coronary Stent Revenue (Millions USD) and Growth Rate (2017-2027)
6.5.6. Japan
6.5.6.1. Japan Coronary Stent Sales and Growth Rate (2017-2027)
6.5.6.2. Japan Coronary Stent Revenue (Millions USD) and Growth Rate (2017-2027)
6.5.6.3.
6.5.7. Korea
6.5.7.1. Korea Coronary Stent Sales and Growth Rate (2017-2027)
6.5.7.2. Korea Coronary Stent Revenue (Millions USD) and Growth Rate (2017-2027)
6.5.8. India
6.5.8.1. India Coronary Stent Sales and Growth Rate (2017-2027)
6.5.8.2. India Coronary Stent Revenue (Millions USD) and Growth Rate (2017-2027)
6.5.9. Southeast Asia
6.5.9.1. Southeast Asia Coronary Stent Sales and Growth Rate (2017-2027)
6.5.9.2. Southeast Asia Coronary Stent Revenue (Millions USD) and Growth Rate (2017-2027)
6.5.10. Rest of Asia-Pacific
6.5.10.1. Rest of Asia-Pacific Coronary Stent Sales and Growth Rate (2017-2027)
6.5.10.2. Rest of Asia-Pacific Coronary Stent Revenue (Millions USD) and Growth Rate (2017-2027)
6.6. South America
6.6.1. South America Coronary Stent Sales and Growth Rate (2017-2027)
6.6.2. South America Coronary Stent Revenue and Growth Rate (2017-2027)
6.6.3. South America Coronary Stent Sales by Countries (2017-2027)
6.6.4. South America Coronary Stent Revenue (Million USD) by Countries (2017-2027)
6.6.5. Brazil
6.6.5.1. Brazil Coronary Stent Sales and Growth Rate (2017-2027)
6.6.5.2. Brazil Coronary Stent Revenue (Millions USD) and Growth Rate (2017-2027)
6.6.6. Argentina
6.6.6.1. Argentina Coronary Stent Sales and Growth Rate (2017-2027)
6.6.6.2. Argentina Coronary Stent Revenue (Millions USD) and Growth Rate (2017-2027)
6.6.7. Columbia
6.6.7.1. Columbia Coronary Stent Sales and Growth Rate (2017-2027)
6.6.7.2. Columbia Coronary Stent Revenue (Millions USD) and Growth Rate (2017-2027)
6.6.8. Rest of South America
6.6.8.1. Rest of South America Coronary Stent Sales and Growth Rate (2017-2027)
6.6.8.2. Rest of South America Coronary Stent Revenue (Millions USD) and Growth Rate (2017-2027)
6.7. Middle East and Africa
6.7.1. Middle East and Africa Coronary Stent Sales and Growth Rate (2017-2027)
6.7.2. Middle East and Africa Coronary Stent Revenue and Growth Rate (2017-2027)
6.7.3. Middle East and Africa Coronary Stent Sales by Countries (2017-2027)
6.7.4. Middle East and Africa Coronary Stent Revenue (Million USD) by Countries (2017-2027)
6.7.5. Saudi Arabia
6.7.5.1. Saudi Arabia Coronary Stent Sales and Growth Rate (2017-2027)
6.7.5.2. Saudi Arabia Coronary Stent Revenue (Millions USD) and Growth Rate (2017-2027)
6.7.6. United Arab Emirates
6.7.6.1. United Arab Emirates Coronary Stent Sales and Growth Rate (2017-2027)
6.7.6.2. United Arab Emirates Coronary Stent Revenue (Millions USD) and Growth Rate (2017-2027)
6.7.7. Egypt
6.7.7.1. Egypt Coronary Stent Sales and Growth Rate (2017-2027)
6.7.7.2. Egypt Coronary Stent Revenue (Millions USD) and Growth Rate (2017-2027)
6.7.8. Nigeria
6.7.8.1. Nigeria Coronary Stent Sales and Growth Rate (2017-2027)
6.7.8.2. Nigeria Coronary Stent Revenue (Millions USD) and Growth Rate (2017-2027)
6.7.9. South Africa
6.7.9.1. South Africa Coronary Stent Sales and Growth Rate (2017-2027)
6.7.9.2. South Africa Coronary Stent Revenue (Millions USD) and Growth Rate (2017-2027)
6.7.10. Rest of Middle East and Africa
6.7.10.1. Rest of Middle East and Africa Coronary Stent Sales and Growth Rate (2017-2027)
6.7.10.2. Rest of Middle East and Africa Coronary Stent Revenue (Millions USD) and Growth Rate (2017-2027)
7. Company Profiles
7.1. Abbott
7.1.1. Business Overview
7.1.2. Product Portfolio
7.1.3. Strategic Developments
7.1.4. Sales, Revenue and Market Share
7.2. Boston Scientific Corporation
7.2.1. Business Overview
7.2.2. Product Portfolio
7.2.3. Strategic Developments
7.2.4. Sales, Revenue and Market Share
7.3. Medtronic
7.3.1. Business Overview
7.3.2. Product Portfolio
7.3.3. Strategic Developments
7.3.4. Sales, Revenue and Market Share
7.4. Terumo Corporation
7.4.1. Business Overview
7.4.2. Product Portfolio
7.4.3. Strategic Developments
7.4.4. Sales, Revenue and Market Share
7.5. B. Braun Melsungen AG
7.5.1. Business Overview
7.5.2. Product Portfolio
7.5.3. Strategic Developments
7.5.4. Sales, Revenue and Market Share
7.6. Biotronik SE & Co. KG
7.6.1. Business Overview
7.6.2. Product Portfolio
7.6.3. Strategic Developments
7.6.4. Sales, Revenue and Market Share
7.7. Stentys SA
7.7.1. Business Overview
7.7.2. Product Portfolio
7.7.3. Strategic Developments
7.7.4. Sales, Revenue and Market Share
7.8. MicroPort Scientific Corporation
7.8.1. Business Overview
7.8.2. Product Portfolio
7.8.3. Strategic Developments
7.8.4. Sales, Revenue and Market Share
7.9. C. R. Bard, Inc.
7.9.1. Business Overview
7.9.2. Product Portfolio
7.9.3. Strategic Developments
7.9.4. Sales, Revenue and Market Share
7.10. Cook Medical
7.10.1. Business Overview
7.10.2. Product Portfolio
7.10.3. Strategic Developments
7.10.4. Sales, Revenue and Market Share
8. Global Coronary Stent Market Competition, by Manufacturer
8.1. Global Coronary Stent Sales and Market Share by Manufacturer (2017-2017)
8.2. Global Coronary Stent Revenue and Market Share by Manufacturer (2017-2017)
8.3. Global Coronary Stent Price by Manufacturer (2017-2017)
8.4. Top 5 Coronary Stent Manufacturer Market Share
8.5. Market Competition Trend
9. Coronary Stent Market Forecast (2027-2023)
9.1. Global Coronary Stent Sales, Revenue (Millions USD) and Growth Rate (2027-2023)
9.2. Coronary Stent Market Forecast by Regions (2027-2023)
9.2.1. North America Coronary Stent Market Forecast (2027-2023)
9.2.1.1. United States Coronary Stent Market Forecast (2027-2023)
9.2.1.2. Canada Coronary Stent Market Forecast (2027-2023)
9.2.1.3. Mexico Coronary Stent Market Forecast (2027-2023)
9.2.2. Europe Coronary Stent Market Forecast (2027-2023)
9.2.2.1. Germany Coronary Stent Market Forecast (2027-2023)
9.2.2.2. United Kingdom Coronary Stents Market Forecast (2027-2023)
9.2.2.3. France Coronary Stent Market Forecast (2027-2023)
9.2.2.4. Russia Coronary Stent Market Forecast (2027-2023)
9.2.2.5. Italy Coronary Stent Market Forecast (2027-2023)
9.2.2.6. Rest of the Europe Coronary Stent Market Forecast (2027-2023)
9.2.3. Asia-Pacific Coronary Stent Market Forecast (2027-2023)
9.2.3.1. China Coronary Stent Market Forecast (2027-2023)
9.2.3.2. Japan Coronary Stent Market Forecast (2027-2023)
9.2.3.3. Korea Coronary Stent Market Forecast (2027-2023)
9.2.3.4. India Coronary Stent Market Forecast (2027-2023)
9.2.3.5. Southeast Asia Coronary Stent Market Forecast (2027-2023)
9.2.3.6. Rest of Asia-Pacific Coronary Stent Market Forecast (2027-2023)
9.2.4. South America Coronary Stent Market Forecast (2027-2023)
9.2.4.1. Brazil Coronary Stent Market Forecast (2027-2023)
9.2.4.2. Argentina Coronary Stent Market Forecast (2027-2023)
9.2.4.3. Columbia Coronary Stent Market Forecast (2027-2023)
9.2.4.4. Rest of South America Coronary Stent Market Forecast (2027-2023)
9.2.5. Middle East and Africa Coronary Stent Market Forecast (2027-2023)
9.2.5.1. Saudi Arabia Coronary Stent Market Forecast (2027-2023)
9.2.5.2. UAE Coronary Stent Market Forecast (2027-2023)
9.2.5.3. Egypt Coronary Stent Market Forecast (2027-2023)
9.2.5.4. Nigeria Coronary Stent Market Forecast (2027-2023)
9.2.5.5. South Africa Coronary Stent Market Forecast (2027-2023)
9.2.5.6. Rest of MEA Coronary Stent Market Forecast (2027-2023)
9.3. Coronary Stent Market Forecast by Product (2027-2023)
9.3.1. Global Coronary Stent Sales Forecast by Product (2027-2023)
9.3.2. Global Coronary Stent Sales Market Share Forecast by Product (2027-2023)
List of Tables
*You can glance through the list of Tables and Figures when you view the sample copy of Coronary Stent Market.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|